David Hallal, CEO at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,794 shares at $135.87 ($380K) on 2016-04-01, disclosed to the SEC on 2016-04-05.
Open-market sale of $380k ALXN by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.87 | 1,380 | $188K | 49.4% |
| 2 | $135.87 | 1,380 | $188K | 49.4% |
| 3 | $136.21 | 34 | $5K | 1.2% |
| Total | $135.87 avg | 2,794 | $380K | 100% |
| Filing → |
| ITOS | SELL | 2025-06-06 | $2.3M | — | Filing → |
| ALVR | SELL | 2022-10-21 | $5.1M | — | Filing → |
| ALVR | SELL | 2022-09-30 | $2.9M | — | Filing → |